BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Bio
Application of Nanotechnology to Novel Models of..
University of North Carolina
Identification of molecular drivers of prostate cancer..
Dr. Efsathiou earned both MD and PhD..
Eleni Efstathiou, MD, PhD:
The University of Texas MD Anderson Cancer Center – Houston, TX
Molecular imaging of prostate cancer to determine..
Michael Evans, PhD:
University of California, San Francisco
Charles Sawyers, MD and Jason Lewis, PhD
Exploiting the genetics of advanced prostate cancer for tumor detection and therapy with transferrin-based radionuclides
Jason A. Efstathiou, MD, DPhil:
Massachusetts General Hospital
Matthew R. Smith, MD, PhD
Predictors of Response and Failure to Radiotherapy for Prostate Cancer in a Randomized Trial
Ederer Investment Company
Evans & Co., LLC is a multi-purpose..
President & Managing Partner of Evans & Co., LLC
Flintridge Capital Investments, LLC
Ben Engel oversees Development and Development Operations..
Vice President, Development Operations